🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Biomed Israel is just two weeks away! We’re proud to share that our CEO & Co-founder, Avi Veidman, will be moderating the session: AI’s Next Leap in HealthTech – From Buzzwords to Real World Examples. See you there! #Biomed #BiomedIsrael #AI #Medtech #biotech

#ASCO25 is around the corner! We're teaming up with Lunaphore (a Bio-Techne brand) and Dr. Paolo Ascierto to present new data on #SpatialBiomarkers in #melanoma. 📅 June 1 | 9–12 CT 📍 Booth IH02 – Live demos + more bit.ly/457Jczd

#AACR25 highlighted the need for better #biomarker strategies to guide the use of antibody-drug conjugates (#ADCs) and #immunotherapy. In our latest blog article, we discuss 3 key updates in #CancerResearch presented at the AACR 2025 conference ➡️ bit.ly/44PWTD3

That’s a wrap on Day 1 of Biomed Israel 2025! We’re just getting started—don’t miss our CEO & Co-founder, Avi Veidman as he moderates tomorrow’s session: Wednesday, May 21 | 15:30 📍 Hall B See you there! #medtech #AI #precisionmedicine #biotech

Meet us at #ASCO25 to explore how AI spatial proteomics and OD-based quantitative scoring of IHC assays can help you derisk your #ADC programs. bit.ly/4dmdXCA #spatialbiomarkers #PrecisionMedicine

Thank you for joining us at Biomed Israel 2025 2025! Our CEO @Avi_ve moderated a powerful panel on turning #AI buzzwords into real-world #healthtech. Big thanks to the speakers from NVIDIA, AWS, AIVF, Eleos, Rounds, VIZ, AISAP & Laguna Health. #DigitalHealth #MedTech #BiomedIsrael25

Live Nucleai Academy webinar 🎓: Learn how OD-based quantitative biomarker scoring can help derisk #ADC drug discovery and development. 📅 June 16 | 11 AM ET 🔗 hubs.li/Q03nZY-90 #ADC #biomarkers #SpatialBiomarker #IHC #mIF #NucleaiAcademy

#Spatialbiology is redefining disease research—moving beyond cell maps to uncover the interactions driving progression and resistance. Our Head of Pathology, Dr. Ken Bloom shares insights in the latest Nature Biotechnology: 🔗 hubs.li/Q03p2kVz0 #spatialbiomarkers

📣📣 Just Announced: An Expanded Suite of ADC #AI #Biomarker Scoring Solutions. Book a demo at #ASCO25 to explore our ADC solution suite for biomarker-informed trial design. Read more → hubs.li/Q03pwZv50 Book a demo → hubs.li/Q03pwYc_0 #spatialbiomarkers

We’re Showcasing an ADC Solution Suite For AI Biomarker Scoring Book a demo at ASCO to see how AI spatial proteomics and OD-based IHC scoring can support your ADC development. 📅 Book a demo → hubs.li/Q03pxhB80

Our ADC Suite of Solutions helps bridge the gap from correlation to causality, delivering clinically meaningful insights from complex data to support biomarker-informed trial design. The suite will be showcased at #ASCO25. Read the announcement → hubs.li/Q03pPNlw0

📢 Our #ASCO25 abstract is now live - developed in collaboration with Lunaphore (a Bio-Techne brand) and Dr. Paolo Ascierto, we present new data on predictive #SpatialBiomarkers in #melanoma. Poster #9524 | June 1 | 9–12 CT 📍 Booth IH02 | Melanoma Session 👉 hubs.li/Q03pZNkr0

It’s showtime! 🎬 We’re all set at ASCO 2025 — stop by Booth IH02 for live demos of our ADC solution suite. #ADCDevelopment #SpatialBiomarkers #AIPathology #DigitalPathology #PrecisionOncology #ASCO25

Missed our poster session today? In collaboration with Lunaphore (a Bio-Techne brand) and Dr. Paolo A. Ascierto, we presented new data on predictive #SpatialBiomarkers in #melanoma. Visit our booth to learn more! bit.ly/3T4smdi #ASCO25

Our #ASCO2025 poster is now live! In collaboration with @lunaphoreand Dr. Paolo A. Ascierto, we present new data using mIF + AI-powered spatial analysis to uncover tumor microenvironment features linked to #immunotherapy response. 📄 bit.ly/4kMWTbB #SpatialBiomarkers

Closing out an incredible week at #ASCO25! Thank you to everyone who stopped by, shared insights, or joined the conversation. Couldn’t make it to Chicago? We’re offering virtual live demos of our ADC solution suite → bit.ly/4mGSit1 #SpatialBiomarkers #DigitalPathology

One week to go! 🎓 Join Dr. Ken Bloom on June 16 for a live #NucleaiAcademy #webinar exploring how OD-based quantitative #biomarker scoring and spatial analysis can support ADC drug development. 📅 Monday, June 16 | 11:00 AM ET RSVP ➡️ hubs.li/Q03rjRhn0

📢This coming Monday, join Dr. Ken Bloom as he explores the challenges of patient selection for ADCs—and how OD-based #biomarker scoring and computational pathology can provide deeper insights into target expression and drug activity.🔗hubs.li/Q03rZctc0 #NucleaiAcademy

Missed our latest #NucleaiAcademy with Dr. Ken Bloom? Watch on demand to explore how OD-based scoring and spatial analysis support ADC development. 📺 Watch the recording: hubs.li/Q03sSWLC0 #biomarkers #precisionmedicine #spatialbiomarkers #aipathology #digitalpathology

In honor of Cancer #Immunotherapy Month, we're highlighting recent research that explores how AI-powered #spatialbiomarkers can help uncover insights into the TME and support a better understanding of treatment response and resistance.#immune2cancer hubs.li/Q03v3ffy0